Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems.
Elevated intraocular pressure (IOP) is the most prevalent and only treatable risk factor for glaucoma, a leading cause of irreversible blindness worldwide. Unfortunately, all current therapeutics used to treat elevated IOP and glaucoma have significant and sometimes irreversible side effects necessi...
Main Authors: | Uttio Roy Chowdhury, Cindy K Bahler, Bradley H Holman, Peter I Dosa, Michael P Fautsch |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4633217?pdf=render |
Similar Items
-
Correction: Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems.
by: Uttio Roy Chowdhury, et al.
Published: (2015-01-01) -
ATP-sensitive potassium (KATP) channel openers diazoxide and nicorandil lower intraocular pressure by activating the Erk1/2 signaling pathway.
by: Uttio Roy Chowdhury, et al.
Published: (2017-01-01) -
Ocular Hypotensive Properties and Biochemical Profile of QLS-101, a Novel ATP-Sensitive Potassium (KATP) Channel Opening Prodrug
by: Casale, R.A, et al.
Published: (2022) -
Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits.
by: Uttio Roy Chowdhury, et al.
Published: (2020-01-01) -
Design, synthesis and biological evaluation of original cromakalim analogues as ATP-sensitive potassium channel openers/Conception, synthèse et évaluation pharmacologique danalogues originaux du cromakalim en tant quactivateurs des canaux potassiques ATP-dépendants
by: Florence, Xavier
Published: (2009)